New guidelines provide a framework for pediatric neuroblastoma treatment — as well as conversations families should have with their oncology teams. Newly crafted guidelines could help guide the ...

A new approach to treating neuroblastoma that could enable therapy with fewer side-effects has been heralded as "promising" by experts. Researchers from the University of Cambridge said their ...

A new study published in Nature Communications heralded some fascinating findings on the future of drug development for neuroblastoma treatment. Cancer that forms in developing nerve cells, ...

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews Last week, we saw a few moving ...

New research shows that GD2 CAR-T cell therapy offers a potential cure for neuroblastoma, with some patients achieving long-term remission for over a decade—marking a major milestone in solid tumor ...

Patients enrolled on the Children's Oncology Group neuroblastoma biology study ANBL00B1 (ClinicalTrials.gov identifier: NCT00904241) who received care at the University of Chicago (UChicago) or the ...

Immunotherapy with a chimeric antigen receptor (CAR) T-cell treatment targeting disialoganglioside GD2 may have a sustained antitumor effect in at least a proportion of pediatric patients with ...

Why retinoic acid is effective in this setting but not against primary tumors, has been speculated about for nearly 50 years. Scientists resolved the mystery, showing the drug 'hijacks' a normal ...

Detailed price information for Actuate Therapeutics Inc (ACTU-Q) from The Globe and Mail including charting and trades.

Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Neuroblastoma Market - A Global and Regional Analysis: Focus on Treatment and Regional Analysis - Analysis and Forecast, 2025-2035" has been added to ...

The woman, who had neuroblastoma as a child, had two healthy pregnancies since undergoing the trial, which uses modified white blood cells to attack cancer cells Getty A woman who underwent a trial ...